Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005612-41Phase 4Active
Phase 4 trial of ascorbic acid in Abnormal wound healing, Skin and connective tissue disease and arteriosclerosis obliterans, sponsored by Meander Medical Center. Primary endpoint: Primary surgical wound area reduction. Started Nov 2015; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005612-41.